t cell re-direction therapy | joshua richter, md | eha 2022
Published 2 years ago • 204 plays • Length 2:18
Download video MP4
Download video MP3
Similar videos
-
57:58
how often should mrd testing occur during remission (and an mrd overview) with dr. joshua richter
-
3:29
t cell redirection therapy | tarek mouhieddine, md | ash 2022
-
1:53
istopmm study and early mgus and smm screening | joshua richter, md | ash 2021
-
1:28
regeneron bispecific antibody targeting bcma update | joshua richter, md | ash 2021
-
5:08
joshua richter, md, talks results from linker-mm1 study
-
2:31
asco/eha 2024 myeloma highlights- imroz, dreamm-7, dreamm-8 | joshua richter, md | eha 2024
-
58:19
sequencing bcma myeloma therapies
-
1:27:49
myeloma crowd radio: joshua richter, md, mount sinai
-
2:01
dr. joshua richter discusses multiple myeloma clinical trials
-
10:16
selinexor in multiple myeloma — dr. joshua richter | mcrt webcast july 11
-
2:13
samuel richter, m.d.
-
3:04
what are celmods in multiple myeloma (& when will they be available?) | dr. joshua richter
-
1:07:46
healthtree podcast for myeloma: joshua richter, md, mount sinai covid update
-
8:56
myeloma research | car-t cell & bispecifics study updates
-
5:02
questions to ask my doctor about new myeloma treatments | dr. joshua richter | the patient story
-
0:59
joshua richter, md, on the phase 3 icaria-mm study from the 61st ash annual meeting and exposition
-
1:25
safety and efficacy of linvoseltamab for patients with r/r multiple myeloma
Clip.africa.com - Privacy-policy